Content Provider for Newsweek

Interviews

Industry

Theodore Leondaridis
Theodore Leondaridis
Global Oncology Head
Pierre Fabre Group
2024-05-11

Our strategic pivot to precision medicine reflects our commitment to more predictable and manageable clinical development processes.

READ MORE
Charles Conroy
Charles Conroy
CEO
Nucleus RadioPharma
2024-05-11

Currently, our primary goal is to establish and expand our operations across the United States. We aim to solidify our infrastructure and ensure we can meet domestic demand before considering international expansion.

READ MORE
Thierry Bernard
Thierry Bernard
CEO
QIAGEN
2024-05-11

QIAGEN has never been better positioned to address these trends – with our differentiated portfolio of molecular testing solutions that help clinicians and researchers gain valuable insights to advance science and improve healthcare.  

READ MORE
James Foster
James Foster
President & CEO
Charles River Laboratories
2024-05-11

Charles River is at the forefront of developing life-saving drugs. Our work is critical in the development of new treatments and bringing these medications to markets where they can make a difference for patients.

READ MORE
Dr. Jeffrey Venstrom
Dr. Jeffrey Venstrom
Chief Medical Officer
GRAIL
2024-05-11

The Galleri test demonstrates a positive predictive value of over 40%, which is a substantial improvement over most traditional single-cancer screenings that often show values below 10%.

READ MORE
Fred Vogt
Fred Vogt
Interim CEO, President & General Counsel
Iovance Biotherapeutics
2024-05-11

Our goal is to build a fully integrated company capable of operating globally. This strategic direction ensures that our innovations reach their full potential without compromising on our vision or values. 

READ MORE
Gilad Almogy
Gilad Almogy
Founder and CEO
Ultima Genomics
2024-05-11

Ultima’s focus spans both direct applications like enabling better testing for individuals and research applications aimed at understanding biology and developing new drugs.

READ MORE
Randy Boldyga
Randy Boldyga
CEO, President & Founder
RXNT
2024-05-11

RXNT stands at the forefront of cloud computing technology after anticipating the shift towards cloud-based solutions early on.

READ MORE
Takashi Toraishi
Takashi Toraishi
Co-CEO & President
Rakuten Medical
2024-05-11

Our technology is a platform technology, meaning we believe it can be adapted to target various cancers by switching the cell-targeting moiety.

READ MORE
Helmy Eltoukhy
Helmy Eltoukhy
Co-Founder, Chairman & Co-CEO
Guardant Health
2024-05-11

Guardant Health has developed a portfolio of tests that revolutionize cancer care, beginning with Guardant360, the world’s first FDA-approved liquid biopsy for therapy selection in advanced-stage cancer patients.

READ MORE